Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration

Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration

The prevalence of serum antibodies against Clostridium difficile (CD) toxins A and B in healthy populations have prompted interest in evaluating the therapeutic activity of intravenous immunoglobulin (IVIg) in individuals experiencing severe or recurrent C. difficile infection (CDI). Despite some pr...

Full description

Bibliographic Details
Main Authors: Negm, Ola H., MacKenzie, B., Hamed, M.R., Ahmad, O.A.J., Shone, Clifford C., Humphreys, D.P., Acharya, K. Ravi, Loscher, Christine E., Marszalowska, Izabela, Lynch, Mark, Wilcox, Mark H., Monaghan, Tanya M.
Format: Article
Published: Wiley 2017
Subjects:
Antibodies
Clostridium difficile
Intravenous immunoglobulin
Online Access:https://eprints.nottingham.ac.uk/44226/

Internet

https://eprints.nottingham.ac.uk/44226/

Similar Items